绿茶水提物对大鼠CYP450酶活力和mRNA表达的调控作用

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1609 KB) HTML (0 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To investigate the potential effects of green tea extract on activities and mRNA expressions of cytochrome P450 (CYP450) enzymes in rats. Methods: After treatment with tea extract or water for 14 days, treatment group rats and control group rats were given the mixture of 4 probe substrates including phenacetin, bupropion, tolbutamide and midazolam. The plasma concentrations of probes at a series of time-points were determined with liquid chromatography tandom mass spectrometry. The activities of CYP450s were evaluated according to the pharmacokinetic parameters of corresponding substrates. Real-time PCR was applied to assess the mRNA expression levels of CYP450s. Results: The pharmacokinetic parameters of bupropion and tolbutamide from treatment group showed significant differences compared with control group, which indicated that green tea extract induced CYP2B1 activity and inhibited CYP2C11 activity. And no significant difference was found in pharmacokinetic parameters of phenacetin or midazolam from treatment group and control group. In addition, treatment with green tea extract significantly up-regulated the mRNA expression of CYP2B1 and down-regulated the mRNA expression of CYP2C11, whereas it had no impact on CYP1A2 and CYP3A1. Conclusion: Continuous ingestion of green tea can modulate the activities and mRNA expressions of CYP2B1 and CYP2C11, which may lead to an undesired interaction.

Key words： green tea extract CYP450 enzyme activity mRNA expression rats

Received: 07 November 2014

	Service
	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHOU Ziye1
	JIN Hui1
	WANG Chenxiang1
	HUANG Aifang1
	WANG Xianqin2
	LIN Guanyang1.

URL:

https://xb.wmu.edu.cn/EN/ OR https://xb.wmu.edu.cn/EN/Y2015/V45/I7/502

[1] Nebert DW, Russell DW. Clinical importance of the cytochromes P450[J]. Lancet, 2002, 360(9340): 1155-1162.
[2] Shord SS, Shah K, Lukose A. Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals[J]. Integr Cancer Ther, 2009, 8(3): 208-227.
[3] Shukla Y. Tea and cancer chemoprevention: a comprehensive review[J]. Asian Pac J Cancer Prev, 2007, 8(2): 155-166.
[4] Yuan JM, Sunb C, Butlerc LM. Tea and cancer prevention:epidemiological studies[J]. Pharmacol Res, 2011, 64(2): 123-135.
[5] Vinson JA. Black and green tea and heart disease: a review [J]. Biofactors, 2000, 13(1-4): 127-132.
[6] Cabrera C, Artacho R, Giménez R. Beneficial effects of green tea-a review[J]. J Am Coll Nutr, 2006, 25(2): 79-99.
[7] Lewis DFV. P450 substrate specificity and metabolism. in: Lewis. Cytochrome P450: structure, function and mechanism[M]. Third Edition. Bristol: Taylor&Francis, 1996: 102-152.
[8] Zhang S, Song N, Li Q, et al. Liquid chromatography/tan-dem mass spectrometry method for simultaneous evaluation of activities of five cytochrome P450s using a five-drug cocktail and application to cytochrome P450 phenotyping studies in rats[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2008, 871(1): 78-89.
[9] Jurica J, Kyr M, McCaskey Hadasova E, et al. Evaluation of the activity of P450 enzymes in rats: use of the single marker or combined drug administration[J]. Neuro Endocrinol Lett, 2009, 30(1): 92-95.
[10] Pekthong D, Desbans C, Martin H, et al. Bupropion hydroxylation as a selective marker of rat CYP2B1 catalytic activity[J]. Drug Metab Dispos, 2012, 40(1): 32-38.
[11] Videau O, Pitarque S, Troncale S, et al. Can a cocktail designed for phenotyping pharmacokinetics and metabolism enzymes in human be used efficiently in rat?[J]. Xenobiotica, 2012, 42(4): 349-354.
[12] Miners JO, Birkett DJ. Cytochrome P4502C9: an enzyme of major importance in human drug metabolism[J]. Br J Clin Pharmacol, 1998, 45(6): 525-538.
[13] 王晋朝, 周宏灏. 细胞色素P450重要成员-CYP2B6研究进展[J]. 医学综述, 2008, 14(4): 483-486.
[14] Wang H, Tompkins LM. CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme[J]. Curr Drug Metab, 2008, 9(7): 598-610.